Mannan-binding protein (MBP), a calcium-dependent plasma lectin, may play a role in the innate defence against microorganisms. After binding lo carbohydrate structures at the bacterial surface, MBP activates the classical pathway of the complement system. To investigate the binding capacity of MBP to various bacteria associated with meningitis, an assay was developed to study the binding of MBP to bacteria grown in a semisynthctic lluid culture medium. Salmonella montevideo (containing a mannose-rich lipopolysaceharide (EPS)), used as a positive control strain, showed binding of radioiabclled MBP at a level of 80% compared with binding of MBP to zymosan. Binding of labelled MBP to Salm. monievideo was time-dependent, temperaturedependent and saturablc. The binding, was inhibited by unlabelled MBP., by mannose and by Nacetyl-ij-glucosamine. Among bacterial pathogens often found to cause meningitis, a wide range of MBP binding capacities could be determined. The encapsulated Neisseriu meningitidis (representatives from 11 serogroups other than group A were included: n ~ 22), N. mucosa {n = \), iUicmophilus mfiuenzae type b \n = 10) and Streptococcus agalactiae [n = 5) had a low MBP binding capacity of21-7% (95% confidence interval (Cl)3'3 4i)\%). Escheriehia coliK\ (« = 11).
INTRODUCTION
in the defence against bacteria causing meningitis, activation of the complement system plays an important role [1] . Inherited or acquired dcfieiencies of the late complement components (C5 C9) or of components belonging to the alternative pathway (factor D, H, and properdin) predispose for bacterial meningitis, in particular due to Neisseria meningitidis [1, 2] . The estimated attack rate of meningitis among complementdeficient persons ranges from 45% to 57% [1.3] . The exact mechanism by which an imact eomplement system is involved in the clearance of bacteria causing meningitis is still unclear. Mannan-binding protein (MBP), an acute phase serum protein with potential antimicrobial activity, belongs to the calcium-dependent lectins [4 %\ MBP is able to bind \o carbohydrate structures present on the surface of bacteria or yeasts [9] [10] [11] [12] , MBP bound to carbohydrates activates the complement system leading to a deposition of complement components on the microbiai cell wall surface [9,13 15] . MBP exhibits both a structural and functional homology with Clq, the lirst component of the classical pathway of the eomplement system, and may represent an important factor in the innate immune defence against microorganisms [16] . Eow serum concentrations of MBP have been shown to be associated with an increased risk of mierobial infection in infants [17] , Such low serum concentrations seem to exist due to certain point mutations in the gene encoding MBP [18 20 ]. Interestingly, the serum concentration of MBP has found to be at the highest level from 6 months toy years of age, including a period of life where maternal antibodies have been eatabolized and the infant's own adaptive immune system has not yet matured [21] .
The purpose of this study was to investigate the MBP binding capacity of various pathogens involved in bacterial meningitis. Since most ofthe bacterial pathogens of meningitis are encapsulated, the influence of bacterial capsules on MBP binding was also studied using unencapsulated mutants,
MATERIALS AND METHODS

Baeteria
Salmonello motitevideo strain.^ 1605 and 5770 (conlainrng mannose-rich polysaccharide subunits of lipopolysaceharide (EPS)), and 3598 (a pmi" mutant of strain 1605 and unable to incorporate mannose in the polysaccharide chain of the EPS), were a gift of Professor Dr P. H. Makela (Helsinki, P'inland). Clinical isolates of neonatal meningitis were Listeria monocylogenes serotype l/2a (n = 4), 1.2b {n = 2) and 4h {n = 5), Escherichia coli K I (/ ( -II) Reagents D-mannose was obtained from Merck (Darmstadt, Germany); N-acetyl-i>-glucosamine (GlcNAe). N-acetyl-n-galaetosamine (GalNAc), mannosaminc. C-rcaclive prolein (CRP), and bovine serum albumin (BSA) were purchased from Sigma (St Eouis, MO).
''^ l-labelling of mannan-binding protein MBP and zymosan were isolated as described before [14] . MBP was labelled with '^^I using tubes coated with 25 jig lodogen [22] . The tube was washed twice wilh TBS (IOMIM Tris, l50mM NaCl, pH 7 4). One hundred micmlitres of TBS with 1% glycerol were pipetted into the tube and IO//I KI of a stock solution of 66/ig/ml in TBS with 1% glycerol and lOO/iCi of '•'"'^INa (Amersham, Aylesbury. UK) were added. The reaction was started by adding 20//g of MBP. .After 12 min e.xposurc at room temperature, a saturaicd KI solution was added to end the reaction. The labelled protein was separated from llic free ' """•INa by gel filtration on a 4-ml Sephadex-50 medium column. Before use in the assays, the radiolabelled MBP was applied to an aflinity eolumn of TSK-75 beads coupled with mannose using divinylsulphone activation of the beads [23] . After washing the column with TBS with 5mM CaCi2 pH 7 4, designated as TBS" , the bound MBP was eluted with TBS with lOmM EDTA pH 7 4. After recalcilication the '^^Iwas ready for use. The final aetivity of the '"^^I-MBP was estimated to be about 1 fiCi//ig protein. The ''^I-MBP was stored at 4 C with 01% BSA added.
SDS-PAGE and autoradiography
Toanaly.se iheradiolabcllcd MBP, SDS PAGE wy.s performed with a 0 75 mm thick, 4-20*% gradient polyaerylamide slab gel under reducing conditions (using 60 mM DTT in the sample buffer) according to the method o\' Eaemmli [24] . Rainbow Markers (Amersham) were used as molecular weight markers. After running the gel. the proteins in the gel were stained with coomassie brilliant blue. An autoradiogram was made by exposing a film to the dried gel for 2 days at -70 C.
Measurements of binding of MBP to zymosan and baeteria
The bacteria were grown to log phase as determined by speetrophotometry at 530 nm and collected by centrifugation at 4000j? for 10 min. The bacteria were washed and the number of colony-forming units (CFU) was adjusted lo approximately 1 X 10'" CFU/ml (MacFarland 3) with PBS pH 7 4 containing 5% BSA. For each test. 300/(1 (approximately 3x10'' bacteria) of this suspension were pipetted in 5-ml plastic tubes and washed twice with TBS. After Ihc final washing the bacteria were suspended in 300//.I of TBS^"^ and incubated with ""I-MBP (lOOOct/min) for 1 h at 37 C. The bacteria were pelleted and the pellet was washed with TBS^' . Pellets and supernatants were counted in a gamma-counter (Beckmann) for 10 min. Each binding assay was performed in duplicate, the background radioactivity was subtracted and the mean activity calculated. Binding of MBP to zymosan (this was approximately 700 XOOet/min) was considered as 100% binding, and the binding of MBP to bacteria was expressed as a percentage of this. The same stock of zymosan was used during all experiments. The binding assay with zymosan was carried out in the same way as for the bacteria.
Inhibition experiments
To test whether the labelled MBP behaved as expected, several proteins (unlabelled MBP, CRP and BSA) and carbohydrates wcTc included in ihe binding assay. The inhibition with EDTA was studied by suspending the bacteria in 50 mM EDTA-TBS buffer before incubation with radiolabelled MBP. In the other inhibition experiments the various proteins and carbohydrates diluted in TBS" * at the indicated concentrations were used to resuspend the bacteria before radiolabelled MBP was added. After this, experiments were continued as described above.
RESLLTS
Preparation and control of'^^l-MBP
The labelling of MBP with '"^I resulted in the incorporation of l"/a of the '"•"! used. Following further fractionation of the labelled MBP by affinity chromatography on mannosecoupled beads, ][)"/<, o\' the labelled MBP was found in the Fig. 1 probably represent serum amyloid P eomponent and dimeric MBP, respectively. No further attempts were made to identify these, as the amounts of these proteins in the preparations were negligible (i.e. less than 1%). The binding of '"^I-MBP to zymosan was shown to be time-and temperature-dependent. At 37 C 70-80% of the maximum amount of ''-^I-MBP was bound to zymosan within 10 min of incubation. The 100% binding was reached after 1 h of incubation, whereas at 4'C this was reached in 4h. The binding of MBP did not occur in the absence of free calcium ions, as demonstrated by inhibition of the binding by 10 mM EDTA (Fig. 2) . The binding could be inhibited by mannose and GlcNAc, but not by mannosamine or GalNAc (Fig. 2) . The binding of '"'^I-MBP to zymosan was diminished by adding increasing amounts of unlabelled MBP, and inhibition was complete when 20//g of MBP were used. The addition of CRP or BSA had no effect.
Binding of MBP to bacteria
When investigating different growth conditions, it appeared that bacteria grown on agar plates or in liquid medium to stationary phase showed a higher MBP binding capacity than bacteria cultured in liquid medium to the log phase. In addition, the inhibition of the binding of MBP to stationary phase bacteria from agar plates needed higher concentrations of EDTA or mannose than stationary phase bacteria obtained from liquid medium, probably reflecting the more complete carbohydrate structures found in these conditions. To standardize the assay, we used in our experiments only bacteria grown to log phase. Semi-synthetic Luria broth was chosen to avoid any influence of carbohydrates which are present in other culture media. Salmonella montevideo was able to bind SO-90% ofthe '^^1-MBP, compared with zymosan. Strains 3598, 1605 and 5770 of Salm, montevideo exhibited similar binding capacity ( Fig. 3 ). Addition of EDTA (50 mM), mannose {80mM) or GlcNAc (80mM) to the binding reaction showed a marked decrease of MBP binding (Fig. 4) . Addition of mannosamine or GalNAc had no effect (data not shown). We found that all the non-encapsulated strains of Salm. montevideo. I.., monocytogenes, N. cinera, and N, subfiava had a high MBP binding capacity ( Fig. 3 ) compared with zymosan of 87-7% (95% confidence interval (Cl) 625 112-5%).
There was no difference in MRP binding of the various L. monocytogenes serotypes tested. Among the encapsulated strains we identified one group with low MBP binding capacity of 21 serogroup A (Fig. 3) . There was no apparent correlation between influence on the MBP binding capaeity and the serotypes within the species Strep, suis. Strep, pneumoniae and Strep, agalactiae. In order to investigate more thoroughly the importanee of encapsulation on the binding of MBP, we compared binding to encapsulated and non-encapsulated vari- ants of TV. meningitidis group B {strains H4476 and 2996) and //. infiuenzae type b (strains f+ and fO). In all strains tested we found a decrease in MBP binding capacity when the capsule was present (Fig. 5 ).
DISCUSSION
MBP has been shown to recognize carbohydrates present in the cell wall of various bacteria. These studies have so far included a few Gram-negative bacteria such as E. coli K12 and J5, Satm. montevideo and Salm. typhimurium and also Gram-positive bacteria such as Strep, pneumoniae and Strep, agalactiae [9] [10] [11] [12] 25] . When bound to bacteria, MBP can promote the deposition of complement components on the eell wall, resulting in lysis of the bacteria [9, 12) . M BP has also been shown to behave as an opsonin directly [10] . This and other studies discussed later, indicate that MBP is an important factor in the innate host defence against microorganisms. To widen the knowledge of possible microbiai ligands we have undertaken a study of the binding of MBP to bacterial pathogens causing meningitis.
When labelled by the proeedure described, 10% ofthe '"'^Ilabelled MBP remained funetionatly active. To isolate the active fraction of the labelled MBP preparation the ''^I-MBP was purified by affinity chromatography on mannose-TSK beads before performing the binding studies. The finding that a relatively high proportion of '""^I-labelled MBP lost its binding capacity suggests that some '"^I can bind to a tyrosine residue within the carbohydrate recognizing site of MBP. After concluding the present study, we found that a procedure by which no non-radioactive iodine in the labelling step was used, results in a much higher proportion (between 50% and 60%) of functional active labelled MBP. In order to study further the binding pattern of the labelled MBP, we performed a series of experiments with zymosan as the ligand of choice, since it is known that zymosan has a good binding capacity for MBP [14] . Binding of '"^I-MBP lo zymosan was ealeium-dependent, and was specifically inhibited by the monosaccharidcs mannose and GlcNAc (Fig. 2) . Maximum binding was achieved after lh at 37 C, and binding was faster at 37 C than at 4X. Using the conditions found to be optimal for '-^1-MBP binding to zymosan. we then studied the binding of MBP to various bacteria. Two strains o\' Salm. montevideo with mannose-rich LPS bound a high amount of MBP, as was expected. The mutant Satm, montevideo strain, with an incomplete o-polysaccharidcs chain lacking mannose, also showed efficient binding of MBP. This indicates that ligands other than mannose (such as GlcNAe residues) are present in the incomplete LPS of the Salm. montevideo strain. The MBP binding to all these strains was speeific, as shown by its inhibition by carbohydrates and EDTA.
When we extended our experiments to the binding of MBP to various bacteria eausing meningitis, a wide range of MBP binding capacities was found ( Fig. 3) . One group of nonencapsulated bacteria with high binding eapacity included L. monoeytogenes. The intermediate binding group eneompassed E, coli K 1, Strep, .vuis. Strep, pneumoniae, and N. meningitidis serogroup A, and the low binding capacity group included A'. meningitidis (other serogroups than A), N, muco.sa, H. infiuenzae type b, and Strep, agalactiae. Overall, it appeared that the presence of a capsule was associated with a marked inhibition of MBP binding. This points to the capsule as a possible interfering factor for the binding of MBP. Fncapsulated A'. meningitidis serogroup B (strains H4476 and 2996) and H, infiuenzae type b (f+ and fO strains) exhibited a low MBP binding in eontrast to their non-encapsulated variants. The effeel of capsules on MBP binding is further illustrated by \he difference of MBP binding capacity between serogroup A and the other meningoeoccal serogroups. The capsule of serogroup A contains repeating units of partially o-acetylated (1 6)linked 2-acetamido-2-deoxy-D-mannopyranosyl phosphate groups which is not present in other meningoeoccal serogroups [26] [27] [28] . This serogroup A structure potentially exposes ManNAc, and it seems likely that this is the ligand for MBP (since it is known to be a good ligand for MBP} in the capsular structure [26.27] . The ability of most of the eneapsulated bacteria to inhibit the binding oi' MBP is an addition to the list of properties such as resistance to lysozyme digestion, the inhibition of complement-mediated lysis and the impairment of phagocytosis, all whieh have been shown to enhance the virulence of encapsulated bacteria [29] . The wide range of MBP binding capacity for different strains belonging to one bacterial species (especially for L. monocytogenes and -V. meningitidis), probably reflects a dilTerence in exposed carbohydrates (e.g. lipopolysaccharides). To study this more thoroughly, we are eurrently developing assays to measure the binding constants and the number of binding sites.
Recognition molecules of the non-adaptive innate immune system such as MBP appear to play an important role in the onset of infeetions before the development of an etficient adaptive humoral and cellular immunity, especially in the period of 3 months to 2 years of age, when maternally acquired antibodies are eatabolized and the infant's own Immune sysiem is still immature. With regard to the ontogeny, MBP rises about two-fold from birth to 3 6 months of age [21] . After 9 years of age MBP levels appear to decline (30] . Thus the concentration of MBP reaches its highest level during the time when the child is most vulnerable to infeetions. Our data further show that among the bacteria causing neonatal meningitis only /.. monoivlogeiies binds MBP to a larger extent. U is possible Ihat a lower level of MBP makes the infant especially vulnerable to this microorganism. This has to be considered in future studies.
It has been found that low concentrations of MBP are associated with a syndrome of frequent unexplained infections in children [17] . The infectious agents in this study were nol ideniified, and there is litlle information on the lype of infeetions with which we should link M BP deficiencies. Sinee MBP is only weakly bound to encapsulated baeteria except N. meningitidis serogroup A, it is unlikely that subjects with low MBP serum levels or an MBP deficiency are at risk for diseases ineluding meningitis due to these encapsulated bacteria. This hypothesis was confirmed in a recent study, in which no association was found between the oeeurrence of meningitis due to serogroup B or C and the MBP serum levels [31] . Neisseria meningitidis serogroup A, causing epidemic meningitis in certain parts of Afriea and China, is found in the Western world as a sporadic cause of meningitis. It will be interesting to study whether these sporadie eases are associated with an MBP defieieney or low scrum MBP levels.
